According to the website of the National Medical Products Administration, the National Conference on Drug Supervision and Administration was held in Beijing from January 6th to 7th. The meeting summarized the drug regulatory work in 2025 and the 14th Five Year Plan, analyzed the current situation, and deployed key tasks for 2026. The meeting pointed out that by 2025, the national drug regulatory system will deepen the reform of drug supervision throughout the entire process, consolidate the bottom line of drug safety in all aspects, support the high-quality development of the pharmaceutical industry throughout the entire chain, record a new high in the number of newly approved innovative drugs and medical devices, maintain overall stability in the national drug safety situation, further enrich the people's sense of gain in drug supervision, and draw a satisfactory conclusion to the development of drug regulatory reform during the 14th Five Year Plan period. In the past five years, the drug regulatory authorities have made new progress in serving the national regional development strategy, the level of drug safety assurance has been further improved, the innovative development of the pharmaceutical industry has achieved new leaps, the international discourse power of drug regulation has reached a new height, and the modernization level of regulation has stepped up to a new level. The main development goals and tasks of the "14th Five Year Plan for National Drug Safety and Promotion of High quality Development" have been successfully completed, and the reform and development of drug regulation have reached a new starting point. The meeting emphasized that the Fourth Plenary Session of the 20th Central Committee of the Communist Party of China and the Central Economic Work Conference have made clear arrangements to strengthen the full chain supervision of drugs, support the development of innovative drugs and medical devices, etc. The drug regulatory authorities should effectively unify their thoughts and actions with the scientific judgment and decision-making deployment of the Party Central Committee on the situation, take effective measures to identify and resolve drug safety risks and hidden dangers, actively support pharmaceutical research and development innovation to improve quality and efficiency, strive to solve the shortcomings and weaknesses in achieving efficient drug regulation, and ensure that the drug regulatory work during the 15th Five Year Plan period starts well. The meeting pointed out that in order to do a good job in drug supervision in 2026, we must conscientiously implement the "four strictest" requirements, follow the work ideas of "emphasizing politics, strengthening supervision, ensuring safety, promoting development, and benefiting people's livelihoods", adhere to the principle of seeking progress while maintaining stability, improving quality and efficiency, and focus on coordinating development and safety, efficiency and fairness, vitality and order, supervision and service. We must effectively use efficient supervision to ensure high-level drug safety, promote high-quality development of the pharmaceutical industry, and benefit the high-quality life of the people, contributing to the construction of a healthy China and a strong pharmaceutical country. The meeting emphasized that in 2026, we should focus on achieving a good start to the "15th Five Year Plan", grasp the key points, have a clear vision, and do the following key tasks well. One is to fully ensure the high-level safety of drugs. Improve the drug safety responsibility system, enhance the level of clinical trial supervision, strengthen the production supervision of high-risk varieties, focus on key varieties such as centralized procurement and selection, increase inspection and sampling efforts, carry out the "clean source" consolidation and improvement action in the drug business process, strengthen online sales supervision, and effectively safeguard the bottom line of drug safety. Secondly, actively support the development of the pharmaceutical industry to improve quality and efficiency. Comprehensively deepen the reform of drug regulation, implement the requirements of "early intervention, one enterprise, one policy, full process guidance, and research and review linkage" for key varieties, support pharmaceutical research and development innovation, promote the innovative development of traditional Chinese medicine, support high-level self-reliance and self-improvement of medical devices, and promote the development and growth of a beautiful economy. The third is to continuously improve the level of rule of law in drug supervision. Continuously improving the legal and regulatory system for drug supervision, perfecting the drug standard system, enhancing the authority and credibility of administrative law enforcement, increasing the publicity of legal knowledge for enterprises and grassroots, and further consolidating the legal foundation of drug supervision. Fourthly, we will solidly promote the modernization of drug supervision. We will develop a high-quality drug plan for the 15th Five Year Plan, solidly promote the integration of national drug regulation, strengthen the construction of regulatory talent and technical support capabilities, deepen the construction of regulatory informationization and scientific research and application of drug regulation, deeply participate in global drug safety governance, and promote the international influence of China's drug regulation to a new level. The meeting requires that with the upcoming Spring Festival and the National People's Congress and the Chinese People's Political Consultative Conference, drug regulatory departments at all levels should strengthen supervision based on the characteristics of drug safety risks, severely crack down on drug related illegal and criminal activities, and ensure the safety of drug use for the people. We must make every effort to do a good job in emergency duty, safety production and other work, do practical things for the masses, solve problems, warm hearts, and create a safe and stable environment for economic and social development. (New Society)